230 related articles for article (PubMed ID: 11904762)
1. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
3. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
4. Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.
Schneider D; Monoranu CM; Huang B; Rutkowski S; Gerber NU; Krauss J; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2009 Jun; 191(2):90-6. PubMed ID: 19446744
[TBL] [Abstract][Full Text] [Related]
5. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
Monoranu CM; Huang B; Zangen IL; Rutkowski S; Vince GH; Gerber NU; Puppe B; Roggendorf W
Cancer Genet Cytogenet; 2008 Apr; 182(1):18-26. PubMed ID: 18328946
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
7. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.
Hulsebos TJ; Oskam NT; Bijleveld EH; Westerveld A; Hermsen MA; van den Ouweland AM; Hamel BC; Tijssen CC
Br J Cancer; 1999 Dec; 81(7):1150-4. PubMed ID: 10584875
[TBL] [Abstract][Full Text] [Related]
8. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
12. Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray.
Ammerlaan AC; de Bustos C; Ararou A; Buckley PG; Mantripragada KK; Verstegen MJ; Hulsebos TJ; Dumanski JP
Genes Chromosomes Cancer; 2005 Aug; 43(4):329-38. PubMed ID: 15880457
[TBL] [Abstract][Full Text] [Related]
13. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
14. Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma.
Ward S; Harding B; Wilkins P; Harkness W; Hayward R; Darling JL; Thomas DG; Warr T
Genes Chromosomes Cancer; 2001 Sep; 32(1):59-66. PubMed ID: 11477662
[TBL] [Abstract][Full Text] [Related]
15. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.
Castells A; Gusella JF; Ramesh V; Rustgi AK
Cancer Res; 2000 Jun; 60(11):2836-9. PubMed ID: 10850424
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
17. Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: a FISH analysis of four cases on touch imprint smears.
Tamiolakis D; Papadopoulos N; Venizelos I; Lambropoulou M; Nikolaidou S; Bolioti S; Kiziridou A; Manavis J; Alexiadis G; Simopoulos C
Cytopathology; 2006 Aug; 17(4):199-204. PubMed ID: 16879268
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers.
Tong CY; Zheng PP; Pang JC; Poon WS; Chang AR; Ng HK
J Neurosurg; 2001 Jul; 95(1):9-14. PubMed ID: 11453403
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
20. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas.
dos Reis PP; Poli-Frederico RC; dos Santos RM; Nishimoto IN; Kowalski LP; Rogatto SR
Med Sci Monit; 2002 Mar; 8(3):BR89-94. PubMed ID: 11889455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
